Atenolol and ischaemic heart disease: an overview

References

• Becker L. C., Fortuin N. J., Pitt B. Effect of ischaemia and anti-anginal drugs on the distribution of radioactive microspheres in the canine left ventricle. Circ. Rex 1971; 28: 263–2691. Becker L. C., Fortuin N. J., Pitt B. Effect of ischaemia and anti-anginal drugs on the distribution of radioactive microspheres in the canine left ventricle. Circ. Rex 1971; 28: 263–269
   PubMed Web of Science ®Google Scholar
• Boyle R. M., Bray C. L., Nayvi N., Croxson R. S., Cruickshank J. M. A comparison of once and twice daily atenolol for angina pectoris. Int. J. Cardiol. 1983; 3: 25–352. Boyle R. M., Bray C. L., Nayvi N., Croxson R. S., Cruickshank J. M. A comparison of once and twice daily atenolol for angina pectoris. Int. J. Cardiol. 1983; 3: 25–35
   PubMed Web of Science ®Google Scholar
• Chierchia S., Glazier J. J., Gerosa S. A single-blind, placebo controlled study of the effects of atenolol on transient ischaemia in 'mixed angina. Am. J. Cardiol. 1987; 60: 36A–40A3. Chierchia S., Glazier J. J., Gerosa S. A single-blind, placebo controlled study of the effects of atenolol on transient ischaemia in 'mixed angina. Am. J. Cardiol. 1987; 60: 36A–40A
   PubMed Web of Science ®Google Scholar
• Chierchia S., Lazzari M., Freedman B., Brunelli C., Maseri A. Impairment of myocardial perfusion and function during painless myocardial ischaemia. J. Am. Coll. Cardiol. 1983; 1: 924–9304. Chierchia S., Lazzari M., Freedman B., Brunelli C., Maseri A. Impairment of myocardial perfusion and function during painless myocardial ischaemia. J. Am. Coll. Cardiol. 1983; 1: 924–930
   PubMed Web of Science ®Google Scholar
• DAVIT II Study Group. Presentation at the American College of Cardiology Meeting, New Orleans, 19905. DAVIT II Study Group. Presentation at the American College of Cardiology Meeting, New Orleans, 1990
   Google Scholar
• De Backer G. G., Derese A. Double-blind, randomised, placebo-controlled study of molsidomine in patients with stable effort angina receiving beta-blocker therapy with atenolol. Am. Heart J. 1985; 109(Pt. 2)678–6816. De Backer G. G., Derese A. Double-blind, randomised, placebo-controlled study of molsidomine in patients with stable effort angina receiving beta-blocker therapy with atenolol. Am. Heart J. 1985; 109(Pt. 2)678–681
   PubMedGoogle Scholar
• Deanfield J. E., Shea M., Ribiero P., De Landsheere C. M., Wilson R. A., Horlock P., Selwyn A. P. Transient ST-segment depression as a marker of myocardial ischaemia during daily life. Am. J. Cardiol. 1984; 54: 1195–12007. Deanfield J. E., Shea M., Ribiero P., De Landsheere C. M., Wilson R. A., Horlock P., Selwyn A. P. Transient ST-segment depression as a marker of myocardial ischaemia during daily life. Am. J. Cardiol. 1984; 54: 1195–1200
   PubMed Web of Science ®Google Scholar
• Fananapazir L., Bray C. Comparison of oxyfedrine and atenolol in angina pectoris– a double-blind study. Br. J. Clin. Pharmacol. 1985; 20: 405–4108. Fananapazir L., Bray C. Comparison of oxyfedrine and atenolol in angina pectoris– a double-blind study. Br. J. Clin. Pharmacol. 1985; 20: 405–410
   PubMed Web of Science ®Google Scholar
• Findlay I. N., Dargie H. J. The effects of nifedipine, atenolol and that combination on left ventricular function. Postgrad. Med. J. 1983; 59: 70–739. Findlay I. N., Dargie H. J. The effects of nifedipine, atenolol and that combination on left ventricular function. Postgrad. Med. J. 1983; 59: 70–73
   PubMed Web of Science ®Google Scholar
• Findlay I. N., Dargie H. J., Gillen G., Elliott A. T. (1985) Effectiveness of nifedipine, atenolol and that combination in patients with angina pectoris. Paper presented at Cardiovascular Pharmacotherapy International Symposium, Geneva, April, 22–251985, Abstr. 28710. Findlay I. N., Dargie H. J., Gillen G., Elliott A. T. (1985) Effectiveness of nifedipine, atenolol and that combination in patients with angina pectoris. Paper presented at Cardiovascular Pharmacotherapy International Symposium, Geneva, April, 22–251985, Abstr. 287
   Google Scholar
• Findlay I. N., Gillen G., Elliott A. T., Dargie H. J. The treatment of angina pectoris with calcium channel and beta-blockers: efficacy and effect on cardiac function. J. Am. CON. Cardiol. 1984; 3: 48211. Findlay I. N., Gillen G., Elliott A. T., Dargie H. J. The treatment of angina pectoris with calcium channel and beta-blockers: efficacy and effect on cardiac function. J. Am. CON. Cardiol. 1984; 3: 482
   Web of Science ®Google Scholar
• Findlay I. N., MacLeod K., Ford M., Gillen G., Elliott A. T., Dargie H. J. Treatment of angina pectoris with nifedipine and atenolol: efficacy and effect on cardiac function. Br. Heart J. 1986; 55: 240–24512. Findlay I. N., MacLeod K., Ford M., Gillen G., Elliott A. T., Dargie H. J. Treatment of angina pectoris with nifedipine and atenolol: efficacy and effect on cardiac function. Br. Heart J. 1986; 55: 240–245
   PubMedGoogle Scholar
• Gibson R. S., Boden W. E., Theroux P., Stauss H. D., Pratt C. M., Gheorghiade M., Capone R. J., Crawford M. H., Schlant R. C., Kleiger R. E., Young P. M., Schechtman K., Perryman M. B., Roberts R. Diltiazem and reinfarction in patients with non-Q-wave myocardial infarction. N. Engl. J. Med. 1986; 315: 423–42913. Gibson R. S., Boden W. E., Theroux P., Stauss H. D., Pratt C. M., Gheorghiade M., Capone R. J., Crawford M. H., Schlant R. C., Kleiger R. E., Young P. M., Schechtman K., Perryman M. B., Roberts R. Diltiazem and reinfarction in patients with non-Q-wave myocardial infarction. N. Engl. J. Med. 1986; 315: 423–429
   PubMed Web of Science ®Google Scholar
• Glazier J. J., Chierchia S., Gerosa S., Crean P. A., Berkenboom G., Maseri A. Atenolol prevents silent and painful ischaemia in patients with mixed angina. Circulation 1986; 74(Suppl. II)A17814. Glazier J. J., Chierchia S., Gerosa S., Crean P. A., Berkenboom G., Maseri A. Atenolol prevents silent and painful ischaemia in patients with mixed angina. Circulation 1986; 74(Suppl. II)A178
   Google Scholar
• Gottlieb S. O., Weisfeldt M. L., Ouyang P., Mellits E. D., Gerstenblith G. Silent ischaemia as a marker for early unfavorable outcomes in patients with unstable angina. N. Engl. J. Med. 1986; 314: 1214–121915. Gottlieb S. O., Weisfeldt M. L., Ouyang P., Mellits E. D., Gerstenblith G. Silent ischaemia as a marker for early unfavorable outcomes in patients with unstable angina. N. Engl. J. Med. 1986; 314: 1214–1219
   PubMed Web of Science ®Google Scholar
• Held P. H., Yusuf S., Furberg C. D. Calcium channel blockers in acute myocardial infarction and unstable angina: an overview. BK Med. J. 1989; 299: 1187–119216. Held P. H., Yusuf S., Furberg C. D. Calcium channel blockers in acute myocardial infarction and unstable angina: an overview. BK Med. J. 1989; 299: 1187–1192
   PubMed Web of Science ®Google Scholar
• ISIS (First International Study of Infarct Survival) Collaborative Group. Randomised trial of intravenous atenolol among 16, 027 cases of suspected acute myocardial infarction. ISIS-I. Lancet 1986; 1: 57–6617. ISIS (First International Study of Infarct Survival) Collaborative Group. Randomised trial of intravenous atenolol among 16, 027 cases of suspected acute myocardial infarction. ISIS-I. Lancet 1986; 1: 57–66
   PubMedGoogle Scholar
• ISIS (First International Study of Infarct Survival) Collaborative Group. Mechanisms for the early mortality reduction produced by beta-blockade started early in acute myocardial infarction. ISIS-1. Lancet 1988; 1: 921–92318. ISIS (First International Study of Infarct Survival) Collaborative Group. Mechanisms for the early mortality reduction produced by beta-blockade started early in acute myocardial infarction. ISIS-1. Lancet 1988; 1: 921–923
   PubMed Web of Science ®Google Scholar
• Jackson G., Harry J. D., Robinson C., Kitson D., Jewitt D. E. Comparison of atenolol with propranolol in the treatment of angina pectoris with special reference to once-daily administration of atenolol. BK Heart J. 1978; 40: 998–100419. Jackson G., Harry J. D., Robinson C., Kitson D., Jewitt D. E. Comparison of atenolol with propranolol in the treatment of angina pectoris with special reference to once-daily administration of atenolol. BK Heart J. 1978; 40: 998–1004
   PubMedGoogle Scholar
• Jackson N. C., Lee P. S., Taylor S. H. A single-blind randomised comparison of the 24 hour anti-anginal efficacy of celiprolol versus atenolol. J. Cardiovasc. Pharmacol. 1986; 8: S145–S14720. Jackson N. C., Lee P. S., Taylor S. H. A single-blind randomised comparison of the 24 hour anti-anginal efficacy of celiprolol versus atenolol. J. Cardiovasc. Pharmacol. 1986; 8: S145–S147
   PubMed Web of Science ®Google Scholar
• Jee L. D., Opie L. H. Double-blind trial comparing Iabetalol with atenolol in the treatment of systemic hypertension with angina pectoris. Am. J. Cardiol. 1985; 56: 551–55421. Jee L. D., Opie L. H. Double-blind trial comparing Iabetalol with atenolol in the treatment of systemic hypertension with angina pectoris. Am. J. Cardiol. 1985; 56: 551–554
   PubMed Web of Science ®Google Scholar
• Kremastinos D., Theodorakis G., Vrachatis A., Kyriakidis Z., Matsakas E., Tout-Ouzas P. Limitation of infarct size after thrombolysis in acute myocardial infarction. The beneficial effect of nitrates and β-adrenergic blockade. Eur. Heart J. 1988; 9: 21222. Kremastinos D., Theodorakis G., Vrachatis A., Kyriakidis Z., Matsakas E., Tout-Ouzas P. Limitation of infarct size after thrombolysis in acute myocardial infarction. The beneficial effect of nitrates and β-adrenergic blockade. Eur. Heart J. 1988; 9: 212
   Google Scholar
• Lai C., Onnis E., Pirisi R., Orani E., Delogu G., Fonzo R., Cherchi A. (1986) Atenolol, nifedipine and their combination in effort angina. Paper read at Tenth World Congress of Cardiology, Washington DC., September, 14–191986, Abstr. 42123. Lai C., Onnis E., Pirisi R., Orani E., Delogu G., Fonzo R., Cherchi A. (1986) Atenolol, nifedipine and their combination in effort angina. Paper read at Tenth World Congress of Cardiology, Washington DC., September, 14–191986, Abstr. 421
   Google Scholar
• Majid P. A., Van der Wigh W. J. F., de Feizter P. J., Wardeh R., Van der Wall E. E., Roos J. P. Once daily atenolol ('Tenormin') in angina pectoris. Observations on clinical efficacy, pharmacokinetics and pharmacodynamics. Eur. J. Cardiol. 1979; 9: 419–43524. Majid P. A., Van der Wigh W. J. F., de Feizter P. J., Wardeh R., Van der Wall E. E., Roos J. P. Once daily atenolol ('Tenormin') in angina pectoris. Observations on clinical efficacy, pharmacokinetics and pharmacodynamics. Eur. J. Cardiol. 1979; 9: 419–435
   PubMedGoogle Scholar
• Maseri A. Spasm and dynamic coronary stenosis. J. Cardiovasc. Pharmacol. 1984; 6: S683–S69025. Maseri A. Spasm and dynamic coronary stenosis. J. Cardiovasc. Pharmacol. 1984; 6: S683–S690
   PubMed Web of Science ®Google Scholar
• McGourty J. C., Silas J. H., Solomon S. A. Addition of verapamil in the treatment of angina resistant to beta-adrenoceptor blockers. Br. J. Clin. Pharmacol. 1984; 17: 638P–639P26. McGourty J. C., Silas J. H., Solomon S. A. Addition of verapamil in the treatment of angina resistant to beta-adrenoceptor blockers. Br. J. Clin. Pharmacol. 1984; 17: 638P–639P
   Web of Science ®Google Scholar
• McLenachan J. M., Findlay I. N., Dargie H. J., O-Neill D. (1985) Betaxolol and atenolol in stable angina pectoris. Paper presented at Cardiovascular Pharmacotherapy International Symposium, Geneva, April, 22–251985, Abstr. 2727. McLenachan J. M., Findlay I. N., Dargie H. J., O-Neill D. (1985) Betaxolol and atenolol in stable angina pectoris. Paper presented at Cardiovascular Pharmacotherapy International Symposium, Geneva, April, 22–251985, Abstr. 27
   Google Scholar
• McLenachan J. M., Findlay I. N., Reid J., McArthur J., Dargie H. J. Beta-blockade following once-daily dosing? A comparison of atenolol and betaxolol. Clin. Sci. 1986; 70: 23728. McLenachan J. M., Findlay I. N., Reid J., McArthur J., Dargie H. J. Beta-blockade following once-daily dosing? A comparison of atenolol and betaxolol. Clin. Sci. 1986; 70: 237
   Google Scholar
• Meyer A., Verheugt F. W. A., Kuyken E. T. Safety of combined early administration of intravenous streptokinase and intravenous atenolol in acute myocardial infarction. Eur Heart J. 1989; 10: 11529. Meyer A., Verheugt F. W. A., Kuyken E. T. Safety of combined early administration of intravenous streptokinase and intravenous atenolol in acute myocardial infarction. Eur Heart J. 1989; 10: 115
   Google Scholar
• MIAMI Trial Research Group. General Discussion. Am. J. Cardiol. 1985; 56: 55G–57G30. MIAMI Trial Research Group. General Discussion. Am. J. Cardiol. 1985; 56: 55G–57G
   Web of Science ®Google Scholar
• Mueller H. S., Ayres S. M. The role of propranolol in the treatment of acute myocardial infarction. Prog. Cardiovasc. Dis. 1977; 19: 405–41231. Mueller H. S., Ayres S. M. The role of propranolol in the treatment of acute myocardial infarction. Prog. Cardiovasc. Dis. 1977; 19: 405–412
   PubMed Web of Science ®Google Scholar
• Mulcahy D., Keegan J., Cunningham D., Quyyumi A., Crean P., Park A., Wright C., Fox K. Circadian variation of total ischaemic burden and its alteration with anti-anginal agents. Lancet 1988; 2: 755–75932. Mulcahy D., Keegan J., Cunningham D., Quyyumi A., Crean P., Park A., Wright C., Fox K. Circadian variation of total ischaemic burden and its alteration with anti-anginal agents. Lancet 1988; 2: 755–759
   PubMed Web of Science ®Google Scholar
• Multicenter Diltiazem Post-Infarction Trial Research Group. The effect of diltiazem on mortality and reinfarction after myocardial infarction. N. Engl. J. Med. 1988; 319: 385–39233. Multicenter Diltiazem Post-Infarction Trial Research Group. The effect of diltiazem on mortality and reinfarction after myocardial infarction. N. Engl. J. Med. 1988; 319: 385–392
   PubMed Web of Science ®Google Scholar
• O'Neill D., Dargie H. J., MacLeod K. Are “long acting nitrates” effective in effort related angina pectoris? BI. Heart J. 1983; 49: 61934. O'Neill D., Dargie H. J., MacLeod K. Are “long acting nitrates” effective in effort related angina pectoris? BI. Heart J. 1983; 49: 619
   Web of Science ®Google Scholar
• Pepine C. J. Clinical aspects of silent myocardial ischaemia in patients with angina and other forms of coronary heart disease. Am. J. Med. 1986; 80(Suppl. 4C)25–3435. Pepine C. J. Clinical aspects of silent myocardial ischaemia in patients with angina and other forms of coronary heart disease. Am. J. Med. 1986; 80(Suppl. 4C)25–34
   PubMed Web of Science ®Google Scholar
• Quyyumi A. A., Wright C., Mockus L., Fox K. M. Effect of partial agonist activity in beta-blockers in severe angina pectoris: a double-blind comparison of pindolol and atenolol. BI. Med. J. 1984; 289: 951–95336. Quyyumi A. A., Wright C., Mockus L., Fox K. M. Effect of partial agonist activity in beta-blockers in severe angina pectoris: a double-blind comparison of pindolol and atenolol. BI. Med. J. 1984; 289: 951–953
   Google Scholar
• Quyyumi A. A., Crake T., Wright C. M., Mockus L. J., Fox K. M. Medical treatment of patients with severe exertional and rest angina, double-blind comparison of beta-blocker, calcium antagonist and nitrate. Br.: Heart J. 1987; 57: 505–51137. Quyyumi A. A., Crake T., Wright C. M., Mockus L. J., Fox K. M. Medical treatment of patients with severe exertional and rest angina, double-blind comparison of beta-blocker, calcium antagonist and nitrate. Br.: Heart J. 1987; 57: 505–511
   PubMed Web of Science ®Google Scholar
• Report of the Holland Inter-University Nifedipine/Metoprolol Trial (HINT) Research Group. Early treatment of unstable angina in the coronary care unit; a randomised, double-blind, placebo controlled comparison of recurrent ischaemia in patients with nifedipine or metoprolol or both. B. Heart J. 1986; 56: 400–41338. Report of the Holland Inter-University Nifedipine/Metoprolol Trial (HINT) Research Group. Early treatment of unstable angina in the coronary care unit; a randomised, double-blind, placebo controlled comparison of recurrent ischaemia in patients with nifedipine or metoprolol or both. B. Heart J. 1986; 56: 400–413
   Web of Science ®Google Scholar
• Richards A. M., Nicholls M. G., Espiner E. A., Ikram H., Cullens M., Hinton D. Diurnal patterns of blood pressure, heart rate and vasoactive hormones in normal man. Clin. Exp. Hypertens. (A) 1986; 8: 153–16639. Richards A. M., Nicholls M. G., Espiner E. A., Ikram H., Cullens M., Hinton D. Diurnal patterns of blood pressure, heart rate and vasoactive hormones in normal man. Clin. Exp. Hypertens. (A) 1986; 8: 153–166
   PubMed Web of Science ®Google Scholar
• Romano M., Di Maro T., Carrella G., Cotecchia M. R., Caiazzo M. R., De Arcangelis E., Chiariello M., Condorelli M. Atenolol and/or nifedipine in effort angina: which is the treatment of choice for exercise coronary protection?. Int. Clin. Pharmacol. Ther: Toxicol. 1988; 26: 468–47040. Romano M., Di Maro T., Carrella G., Cotecchia M. R., Caiazzo M. R., De Arcangelis E., Chiariello M., Condorelli M. Atenolol and/or nifedipine in effort angina: which is the treatment of choice for exercise coronary protection?. Int. Clin. Pharmacol. Ther: Toxicol. 1988; 26: 468–470
   Web of Science ®Google Scholar
• Roy P., Day L., Sowton E. Effect of new beta-adrenergic blocking agent, atenolol ('Tenormin'), on pain frequency, trinitrin consumption, and exercise ability. Br.:Med. J. 1975; 3: 195–19741. Roy P., Day L., Sowton E. Effect of new beta-adrenergic blocking agent, atenolol ('Tenormin'), on pain frequency, trinitrin consumption, and exercise ability. Br.:Med. J. 1975; 3: 195–197
   PubMed Web of Science ®Google Scholar
• Sanchez Cascos A., Gene G., Martinez J. A., De Rabago Gonzalez P., Bros Caimari R., Garcia Gallego F. Ensayo clinico del neuvo betabloqueante atenolol. Rev. ESP. Cardiol. 1977; 30: 545–54842. Sanchez Cascos A., Gene G., Martinez J. A., De Rabago Gonzalez P., Bros Caimari R., Garcia Gallego F. Ensayo clinico del neuvo betabloqueante atenolol. Rev. ESP. Cardiol. 1977; 30: 545–548
   PubMedGoogle Scholar
• Schwartz J. B. Atenolol in the treatment of angina. Once-daily cardioselective beta-blockade for angina pectoris. Drugs 1983; 25(Suppl. 2)160–16543. Schwartz J. B. Atenolol in the treatment of angina. Once-daily cardioselective beta-blockade for angina pectoris. Drugs 1983; 25(Suppl. 2)160–165
   Google Scholar
• Selwyn A. P., Fox K., Eves M., Oakley D., Dargie H., Shillingford J. Myocardial ischaemia in patients with frequent angina pectoris. Br.: Med. J. 1978; 2: 1594–159644. Selwyn A. P., Fox K., Eves M., Oakley D., Dargie H., Shillingford J. Myocardial ischaemia in patients with frequent angina pectoris. Br.: Med. J. 1978; 2: 1594–1596
   PubMed Web of Science ®Google Scholar
• Shapiro W., Narahara K. A., Kostis J. B., Thandroyen F., Zohman L. R. Comparison of atenolol and nifedipine in chronic stable angina pectoris. Am. J. Cardiol. 1989; 64: 186–19045. Shapiro W., Narahara K. A., Kostis J. B., Thandroyen F., Zohman L. R. Comparison of atenolol and nifedipine in chronic stable angina pectoris. Am. J. Cardiol. 1989; 64: 186–190
   PubMed Web of Science ®Google Scholar
• Sheridan J. V., Thomas P., Routledge P. A., Sheridan D. J. Effects of felodipine on haemodynamics and exercise capacity in patients with angina pectoris. Br.: J. Clin. Pharmacol. 1987; 23: 391–39646. Sheridan J. V., Thomas P., Routledge P. A., Sheridan D. J. Effects of felodipine on haemodynamics and exercise capacity in patients with angina pectoris. Br.: J. Clin. Pharmacol. 1987; 23: 391–396
   PubMed Web of Science ®Google Scholar
• Simonsen S. Effect of atenolol (ICI 66.082) on coronary haemodynamics in man. Br Heart J. 1977; 39: 1210–121647. Simonsen S. Effect of atenolol (ICI 66.082) on coronary haemodynamics in man. Br Heart J. 1977; 39: 1210–1216
   PubMedGoogle Scholar
• Sowton E. Effects of atenolol in angina. Postgrad. Med. J. 1977; 53: 90–9348. Sowton E. Effects of atenolol in angina. Postgrad. Med. J. 1977; 53: 90–93
   PubMed Web of Science ®Google Scholar
• Yamaguchi H. (1989) Dynamic coronary stenosis in stable angina. Paper presented at Symposium “Evolving Concepts in Ischaemic Heart Disease, San Francisco, January, 13–15198949. Yamaguchi H. (1989) Dynamic coronary stenosis in stable angina. Paper presented at Symposium “Evolving Concepts in Ischaemic Heart Disease, San Francisco, January, 13–151989
   Google Scholar
• Yusuf S., Sleight P., Rossi P., Ramsdale D., Peto R., Furze L., Sterry H., Pearson M., Motwani R., Parish S., Gray R., Bennett D., Bray C. Reduction in infarct size, arrhythmias and chest pain by early intravenous beta-blockade in suspected acute myocardial infarction. Circulation. 1983; 67(Suppl. 1)32–4150. Yusuf S., Sleight P., Rossi P., Ramsdale D., Peto R., Furze L., Sterry H., Pearson M., Motwani R., Parish S., Gray R., Bennett D., Bray C. Reduction in infarct size, arrhythmias and chest pain by early intravenous beta-blockade in suspected acute myocardial infarction. Circulation. 1983; 67(Suppl. 1)32–41
   Google Scholar
• Yusuf S., Peto R., Lewis J., Collins R., Sleight P. Beta-blockade during and after myocardial infarction: an overview of the randomised trials. Progr. Cardiovasc. Dis. 1985; 25: 335–37151. Yusuf S., Peto R., Lewis J., Collins R., Sleight P. Beta-blockade during and after myocardial infarction: an overview of the randomised trials. Progr. Cardiovasc. Dis. 1985; 25: 335–371
   Google Scholar